Skip to main content

The Greater Intermountain Node

The Greater Intermountain Node (GIN) was founded in 2019 to expand the existing National Institute of Drug Abuse Clinical Trial Network (CTN) infrastructure by developing and testing innovative interventions for opioid use disorder, preventing overdose, expanding the settings for Network research, and bringing new research expertise of opioid addiction research to the Utah, regional, and national communities.


The Greater Intermountain Node (GIN) is housed within the Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA) at the University of Utah. The GIN brings particular expertise in three areas of opioid addiction research to the Utah, regional, and national communities:

  1. Research within non-addiction specialty health care settings.
  2. Addiction and opioid research within large health systems of care.
  3. Implementation science and approaches to bring addiction evidence based research to practice.

The GIN leverages robust institutional commitment and infrastructure, institutional centers focused on addiction-related research, and training programs with strong regional and national connections to clinicians, educators, other institutions and organizations, and community stakeholders. 


    Adam Gordon, MD, MPH

    GIN Co-Principal Investigator

    Dr. Adam Gordon is the Elbert F. and Marie Christensen Endowed Research Professor, tenured Professor of Medicine and Psychiatry, at the University of Utah School of Medicine and the Section Chief of Addiction Medicine at the VA Salt Lake City Health Care System. Dr. Gordon has a 20+ year track record of conducting research on the quality, equity, and efficiency of health care for vulnerable populations, including those who are homeless or who have addiction.

    Gerald Cochran, PhD, MSW

    GIN Co-Principal Investigator

    Dr. Gerald Cochran is an Associate Professor in the Department of Internal Medicine, Division of Epidemiology at the University of Utah and also has an adjunct Associate Professor appointment with the University of Utah Department of Psychiatry and is core faculty with the Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center of Innovation within the VA Salt Lake City Health Care System.

    Kristi Carlston

    GIN Clinical Research Manager

    Kristi has ten years of progressive research experience that includes design, implementation and management of clinical research projects in an academic setting. She received her bachelor's at the University of Utah in Health Promotion and is certified as a Clinical Research Coordinator through the Association of Clinical Research Professionals. She is responsible for coordination support to study investigators, staff and data management on several multi-site projects.

    Priscilla Blosser, RN

    Sr. Clinical Research Coordinator

    Grace Broussard

    Clinical Research Coordinator

    Elysha Cash

    Clinical Research Coordinator

    Stephanie Castro, MPH

    Clinical Research Coordinator

    Cole Fordham

    Study Coordinator

    Jacob Foringer

    Study Coordinator

    Mitchell Garets, MSW

    Academic Program Manager

    Brady Groneman

    Clinical Research Coordinator

    Clint Hardy, PhD

    Research Associate

    Grace Humiston

    Sr. Clinical Research Coordinator

    Katie Kinsey, LCSW

    Social Service Worker

    Nicole Mauerman, MS

    Sr. Regulatory Coordinator

    Carter Reeves

    Clinical Study Assistant

    Navid Sadeghi

    Study Coordinator

    John Saunders, PharmD

    Clinical Pharmacist

    Britnee Sengpraseut

    Clinical Research Coordinator

    Laura Stolebarger, RN, CM

    Kathryn Szczotka, MPH

    Sr. Clinical Research Coordinator

    Ashley White, CMHC

    Program Manager

    Greater Intermountain Node


    For the best way to stay up to date with our node, join our email listsev. Emails include invites to upcoming seminars, grant opportunities, job openings, and more!

    Greater Intermountain Node


    Data is everywhere and expansive. Incorporating data science as a new tool for the study of substance use disorders can be leveraged to reveal new aspects of addiction biology and treatment.

    Learn more about the data science initiatives happening here at the Greater Intermountain Node.


    Affiliate Faculty

    Amanda Allshouse, MS

    Amy Butz, PharmD

    Alyrene Dorey, MD

    A. Taylor Kelley, MD, MPH, MS

    Ami Stuart, PhD, MA, MS

    Ana Holtey, DO

    Audrey Jones, PhD

    Ben Brintz, PhD, MS

    Billinda Tsuya, PA-C

    Brian C. Sauer, PhD, MS

    Christina L. Gallop, MD

    Danielle Babbel, MD

    Daniel W. Odell, MD

    Eric L. Garland, PhD, LCSW

    Elizabeth Howell, MD, MS

    Emily Spivak, MD, MHS

    Eamonn Kennedy, PhD, MS

    Grace LaFluer, PharmD

    Jake S. Magel, PhD, DSc, MSPT

    Jasmin E. Charles, PA-C, MPAS

    Jeremy E. Thueson, MD

    John W. Gardner, PharmD

    Julia Lewis, DO

    Julie Day, MD

    Julie M. Fritz, PhD, PT, ATC

    Ken B. Johnson, MD, MS

    Kristina Lisa Allen-Brady, PhD, MSPH, BA, MPT

    Kristine A. Campbell, MD, MSc

    Marcela C. Smid, MD, MA, MS

    Mary Jo Pugh, PhD, RN

    Mathew Mulligan, MD

    Matthew H. Samore, MD

    Megan E. Vanneman, PhD, MPH

    Michael A. Incze, MD, MSEd

    Michelle Debbink, MD, PhD

    Molly B. Conroy, MD, MPH, FACSM, FAHA

    Natalie Valentino, PharmD

    Nasser Sharareh, PhD

    Nicholas Cox, PharmD, BCACP

    Peter P. Taillac, MD

    Rana Jawish, MD

    Richard Nelson, PhD, MA, MS

    Scott R. Junkins, MD

    Troy E. Madsen, MD, FACEP


    Mailing Address:

    383 Colorow Drive, Mailbox 16

    Salt Lake City, Utah 84108



    (801) 213-0806





    The Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA) promotes and provides addiction related research, clinical care, knowledge and advocacy across the University of Utah, the local community, the state, and the nation.



    NIDA Clinical Trials Network

    The National Institute of Drug Abuse (NIDA) Clinical Trial Network (CTN) provides an enterprise in which NIDA, treatment researchers, and community-based service providers work toward new treatment options in community-level clinical practice.